Core Viewpoint - Duori Pharmaceutical is undergoing a potential change in control, which may lead to a shift in its major shareholder and actual controller, with stock suspension expected for no more than two trading days [1] Group 1: Company Overview - Duori Pharmaceutical primarily engages in the research, production, and sales of chemical drug formulations, intermediates, and active pharmaceutical ingredients [1] - The company was listed on the Shenzhen Stock Exchange's Growth Enterprise Market in September 2021 [1] Group 2: Financial Performance - The company has experienced a continuous decline in net profit from 2021 to 2024, with figures of 68.51 million, 20.50 million, 18.85 million, and a loss of 62.67 million respectively, reflecting year-on-year decreases of 25.53%, 70.07%, 8.05%, and 432.44% [1][2] - Revenue has also decreased for three consecutive years, with 2022 to 2024 revenues of 401 million, 334 million, and 241 million, showing year-on-year declines of 24.28%, 16.64%, and 28.02% [2] - In the first half of 2025, revenue continued to decline to 107 million, a year-on-year decrease of 29.13%, with a net profit loss of 42.50 million compared to a loss of 3.28 million in the same period last year [2] Group 3: Profitability and Financial Ratios - The company's gross margin has sharply declined from 88.61% in 2021 to 42.42% in 2024, plummeting to 4.07% in the first half of 2025 [2] - The asset-liability ratio increased significantly from 23.37% at the end of 2023 to 50.91% at the end of 2024, further rising to 52.01% by mid-2025 [2]

Group 1: Control Change Announcements - Multiple A-share companies, including Duori Pharmaceutical, Asia-Pacific Pharmaceutical, and Zhonghuan Environmental Protection, announced plans for control changes on September 28 [1][3][4] - Duori Pharmaceutical's controlling shareholder, Tibet Jiakang Times Technology Development Co., Ltd., is planning a control change, leading to a potential change in the actual controller [1] - Asia-Pacific Pharmaceutical's controlling shareholder, Ningbo Fubang Holding Group Co., Ltd., is also planning a control change, with no formal agreement signed yet [3] - Zhonghuan Environmental Protection's controlling shareholder, Zhang Bozhong, is in the process of planning a control change, which may affect the actual controller [4] Group 2: Company Profiles and Operations - Duori Pharmaceutical specializes in the R&D, production, and sales of chemical drug formulations and intermediates, with leading market share in products like Acetate Sodium Ringer Injection [1] - Asia-Pacific Pharmaceutical focuses on pharmaceutical manufacturing, including the R&D and sales of chemical formulations, with a portfolio of 114 approved formulations [3] - Zhonghuan Environmental Protection is a national high-tech enterprise engaged in water environment governance and waste treatment, providing comprehensive solutions in various segments [5] - Guanzhong Ecology is undergoing a control change with a share transfer agreement to Deep Blue Whale, which will result in a new controlling shareholder [7]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 控股股东或实际控制人变更的主要内容 ■ （一）前期权益变动情况概述 2025年8月26日10时至2025年8月27日10时（延时除外），广东省深圳市福田区人民法院（以下简称"福 田法院"）对唯之能源持有的公司150,000,000股无限售流通股在京东网司法拍卖网络平台 （https://paimai.jd.com/）上进行了公开拍卖，上述股份被平均拆分为3批，每批50,000,000股同时上拍， 且分别被3名买受人拍得。拍卖详情参见公司于2025年8月28日在上海证券交易所网站 （www.sse.com.cn）披露的《亿晶光电科技股份有限公司关于控股股东所持公司股份被第二次司法拍卖 的进展公告》（公告编号：2025-054）。 2025年9月1日，上述经司法拍卖的股份中50,000,000股完成非交易过户，彼时唯之能源所持股份总数由 150,000,000股减少至100,000,000股，占公司当前总股本的比例 ...

若本次交易顺利完成，良品铺子控股股东将由宁波汉意变更为长江国贸。 9月26日下午，良品铺子召开2025年半年度业绩说明会，公司控制权变更事宜因涉及多方权益与诉讼争议，成为了投资者关注焦点。 回溯事件脉络，7月，良品铺子突发公告，公司控股股东宁波汉意及其一致行动人良品投资，拟以10.46亿元总价向武汉国资长江国贸转让合计21%股 份。同时，公司二股东达永有限也拟以4.45亿元的价格向长江国贸转让其持有的8.99%股权。 业绩会上，多位投资者围绕与广州轻工的股权纠纷进展接连提问，希望了解事件最新动态及对公司的潜在影响。 对此，良品铺子总经理杨红春并未透露更多细节，仅表示"公司将根据法律法规的规定及时进行信息披露，敬请广大投资者注意投资风险"。 同时杨红春强调，该事项对公司生产经营和当期损益无重大影响。"公司目前各项业务经营情况正常，并将继续围绕公司发展战略，提升公司可持续发 展及盈利能力，为公司和股东创造更大价值。" 左宇摄 然而，这一控制权转让进程却意外受阻。此前已与宁波汉意签署《协议书》、就控制权转让有过接触的广州国资广州轻工，对上述股权转让事项明确提 出反对，并已就此发起诉讼。受此影响，良品铺子控制权转让事 ...

中国经济网北京9月26日讯 天汽模(002510.SZ)今日股价涨停，截至发稿报7.39元，上涨9.97%。 天汽模昨晚披露了关于控股股东、实际控制人签署股份转让协议暨控制权拟发生变更的提示性公 告。 据天汽模公告，2025年9月24日，公司控股股东、实际控制人胡津生、常世平、董书新、任伟、尹 宝茹、张义生、鲍建新、王子玲与新疆建发梵宇产业投资基金合伙企业（有限合伙）（以下简称"建发 梵宇"）签署了《关于天津汽车模具股份有限公司之股份转让协议》（以下简称"《股份转让协 议》"）。 胡津生、常世平、董书新、任伟、尹宝茹、张义生、鲍建新、王子玲拟向建发梵宇转让其持有的上 市公司股份合计161,779,192股无限售条件流通股，占上市公司总股本的15.9367%。 经各方协商一致，本次标的股份的每股转让价格为人民币6.364元，股份转让价款总计为人民币 1,029,562,778元。 同时，任伟承诺自交割日起放弃其持有的上市公司除其拟转让股份之外的10,238,094股股份（占公 司股份总数的1.0085%，以下称"剩余股份"）所对应的根据法律、法规、规章及其他具有法律约束力的 规范性文件或公司章程需要股东大会讨论 ...

此次股份过户完成后，安吉以清及其实际控制人金亚伟先生合计持有公司25%股份及对应表决权，菲林 格尔实际控制人正式由丁福如先生变更为金亚伟先生。此外公告明确，本次协议转让过户符合《上海证 券交易所股票上市规则》等多项法律法规及规范性文件要求。同时，受让方安吉以清承诺，在股份过户 完成后的36个月内不以任何形式减持本次受让股份，因送红股、资本公积金转增股本等增加的股份亦遵 守该限售安排；和融联基金则承诺18个月内不减持受让股份。市场分析人士指出，此次交易将有助于稳 定公司股权结构，为新管理层推进战略落地提供保障。（CIS） 另一方面，公司5%以上股东菲林格尔控股有限公司将1780万股（占公司总股本5.01%）无限售流通股转 让给和融联（广州）私募基金管理有限公司-和融联融典私募证券投资基金（下称"和融联基金"）。转 让前菲林格尔控股持股9676.46万股（占比27.22%），转让后持股量为7896.4554万股，持股比例降至 22.21%。值得注意的是，菲林格尔控股向陕国投·乐盈267号信托、渤源达朗基金转让剩余股份的手续仍 在办理中。 9月22日晚，菲林格尔（603226.SH）发布公告称，公司实际控制人及5% ...

Core Viewpoint - The recent changes in the management of Red Star Macalline are closely linked to the shift in control following the acquisition by Xiamen Jianfa, which has led to a wave of executive departures and significant financial losses for the company [5][6][7]. Group 1: Management Changes - Founder Che Jianxing has been released from detention by the Yunnan Provincial Supervisory Committee, marking his return to the public eye after four months [2]. - A significant turnover in the executive team has occurred, with four high-level departures in September alone, including the resignation of the board secretary and vice president due to personal career planning [3][4]. - The new controlling shareholder, Xiamen Jianfa, has initiated a major management overhaul, appointing former Jianfa executives to key positions within Red Star Macalline [6]. Group 2: Ownership and Control - In June 2023, Xiamen Jianfa acquired a 29.95% stake in Red Star Macalline for approximately 6.286 billion yuan, becoming the controlling shareholder [5][6]. - Following the acquisition, Che Jianxing exited the list of actual controllers, with Xiamen Jianfa now holding the largest share at 23.95% [6]. Group 3: Financial Performance - Red Star Macalline has reported significant financial losses, with net losses of 2.216 billion yuan in 2023 and 2.983 billion yuan in 2024, and a further loss of 1.9 billion yuan in the first half of 2025, marking the lowest net profit for the company since its listing [7]. - The company attributed its ongoing losses to store closures, rental discounts, and a 2.1 billion yuan loss from changes in the fair value of investment properties [7]. - As of June 30, 2025, Red Star Macalline faced substantial short-term debt pressures, with a total of 15.47 billion yuan in short-term loans and 5.738 billion yuan in non-current liabilities due within a year [7].

Core Viewpoint - The article discusses the recent developments at Red Star Macalline, including the return of founder Che Jianxing after the lifting of his detention, a wave of executive departures, and the impact of Xiamen Jianfa's acquisition on the company's management and performance [2][4][7]. Group 1: Executive Changes - Che Jianxing, the founder of Red Star Macalline, has had his detention lifted by the Yunnan Provincial Supervisory Committee, allowing him to return to the public eye [2][4]. - A significant turnover in the executive team has been noted, with four high-level departures in September alone, including the resignation of the board secretary and vice president Qiu Zhe due to personal career planning [3][5]. - The departures of executives, including former Alibaba executives, have raised speculation about the strategic relationship between Alibaba Group and Red Star Macalline [5]. Group 2: Ownership Changes - In June 2023, Xiamen Jianfa, a state-owned enterprise, acquired a 29.95% stake in Red Star Macalline for approximately 6.286 billion yuan, becoming the controlling shareholder [7][8]. - Following this acquisition, Che Jianxing exited the role of actual controller, with Xiamen Jianfa and its affiliates becoming the largest shareholders [8]. - The management team has undergone significant changes, with new appointments from the Jianfa Group, including Li Yupeng as chairman and Shi Yaofeng as general manager [8]. Group 3: Financial Performance - Red Star Macalline has reported continuous financial losses, with net losses of 2.216 billion yuan in 2023, 2.983 billion yuan in 2024, and 1.9 billion yuan in the first half of 2025, marking the lowest net profit for the company since its listing [11]. - The decline in performance is attributed to store closures and rental discounts, alongside a significant loss of 2.1 billion yuan from changes in the fair value of investment properties [11]. - As of June 30, 2025, the company faces substantial short-term debt pressures, with a total of 15.47 billion yuan in short-term loans and 5 billion yuan in interest-bearing debt due [11].

长江商报奔腾新闻记者 邹平 杨恩光成为冠中生态重要股东至今不过15个月时间。2024年6月，杨恩光通过受让李春林家族所持有的 部分股份，获得了6%的股权。 当时公司控股股东冠中投资通过协议转让方式将其持有的840.06万股转让给自然人杨恩光，转让股份占 公司总股本的6.07%。标的股份的转让价格为8.5元/股，转让价款合计为7140.51万元。 以当前冠中生态停牌11.2元/股的股价计算，杨恩光近期减持浮盈约30%。 冠中生态于2021年2月25日在深交所创业板上市，发行价格为13元/股。然而公司的业绩和股价表现可谓 是"上市即巅峰"。 长江商报奔腾新闻记者查阅公司财报发现，2022年至2024年，冠中生态营业收入分别是4.53亿元、3.77 亿元及1.45亿元，归母净利润分别5623.46万元、3417.21万元及-7090.02万元，同比降幅分别为28.02%、 上市四年，业绩连续下滑，股价较高位跌去四分之三，冠中生态（300948.SZ）实控人最终选择"一把梭 哈卖公司"。 9月21日晚间，冠中生态公告称，收到控股股东青岛冠中投资集团有限公司及实际控制人李春林、许剑 平夫妇通知，其正在筹划公司控制权变更 ...

Core Viewpoint - The article discusses the control change and share reduction of Guanzhong Ecology, highlighting the trend of major shareholders cashing out shortly after the lock-up period, raising concerns about the company's performance post-IPO [2][9]. Company Background - Guanzhong Ecology was initially listed on the New Third Board on November 24, 2015, and later transitioned to the A-share market, successfully listing on the ChiNext on February 25, 2021, becoming the first listed company in Qingdao in the Year of the Ox [6][7]. - The company specializes in ecological restoration services, including vegetation recovery, industrial tailings management, and desertification control [6]. Shareholder Actions - The actual controllers, Li Chunlin and Xu Jianping, had their shares locked for three years post-IPO, with 70.35 million shares (50.24% of total shares) set to be unlocked on February 26, 2024 [10][11]. - Just three months after the lock-up expiration, the actual controllers initiated a significant share reduction, transferring 8.4 million shares (6.07% of total shares) to individual Yang Enguang at a price of 8.5 yuan per share, totaling approximately 71.41 million yuan [12][13]. Financial Performance - The company's revenue grew from 151 million yuan in 2016 to 402 million yuan in 2021, but subsequently faced a decline, with a net loss of 78.18 million yuan in 2024 and a revenue drop back to levels seen eight years prior [15][16]. - The company's stock price peaked at 47.58 yuan shortly after listing but has since fallen to around 11.2 yuan, representing a decline of over 75% from its peak [17]. Financing Activities - Despite the declining performance, Guanzhong Ecology has successfully raised over 700 million yuan since its IPO, including a 400 million yuan convertible bond issuance in July 2023 [19][21]. - The company has distributed a total of approximately 30 million yuan in dividends over the past six years, indicating a low return to shareholders compared to the capital raised [21][22].